Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Avatar Builder | Contact Info | Update Email | Update Password | Leaderboards | Manage Favourite | Reputation | Reputation History | Subscriptions | Payment Info | Invoices | Favourites

Bullboard Post History

by MicrocapManiac

Order by:

T.CPH	RE: 'Yea, 8 Cylinders is Better...wonder if...? A takeover would need a much higher price then $10. I doubt Dr Moll, who owns... May 28, 2013
V.RX	Diddly likes RX.V Diddly likes RX.V. It helps explain some of the volume over the last couple... May 27, 2013
T.CPH	Jason Donville - DND Jason Donville of Donville Kent Asset likes Cipher Pharma, DND.T... May 27, 2013
T.CPH	Healthcare Conference Cipher will be a presenter at the Bloom Burton healthcare conference next... May 16, 2013
T.CPH	Healthcare Conference Cipher will be a presenter at the Bloom Burton healthcare conference next... May 16, 2013
T.CPH	Healthcare Conference Cipher will be a presenter at the Bloom Burton healthcare conference next... May 16, 2013
T.CPH	RE: Absorica 9.4% as of Apr 29, 2013 With a 9.4% market share for Absorica and roughly $0.06 annual contibution... May 16, 2013
T.CPH	Absorica 9.4% market share Absorica has a 9.4% market shares as of April. http://www.siliconinvestor.com... May 15, 2013
T.CPH	Byron Capital ups Cipher price target Cipher's other analyst decides Cipher is worth more. http... May 7, 2013
T.CPH	New Price Target Zacks has upped their price target to $6.50. I still think they are too low. ... May 6, 2013
T.CPH	New Price Target Zacks has upped their price target to $6.50. I still think they are too low. ... May 6, 2013
T.CPH	RE: RE: Absorica US Market Size I understand that the $750 for 30 40mg tablets is a one month supply and... April 8, 2013
T.CPH	5% market share Cipher's new investor presentation shows that Absorica had reached a 5... April 6, 2013
T.CPH	Cipher Pharma is similar to Obagi, but much cheape Cipher Pharma is similar to Obagi, but much cheaper, says Byron... April 4, 2013
T.PHO	RE: P/E of 5x, P/CF of 3x It is cheap. They did $1.7 million in profit or about $0.016 in eps. They had... March 25, 2013
V.MCR	RE: RE: Equalled our closing high of $2.42 So is MCR. March 24, 2013
ENTCF	ENT vs MCR I've taken down a rather large position in MCR.V, nothing yet in ENT, and... March 18, 2013
V.MCR	RE: RE: RE: Buyer of MCR at $2-come to papa I'm no longer waiting for $2.00. I got some today at $2.14 and $2.16. I... March 18, 2013

Featured News Links

Major Funding Secured! Company Closes First Round of Private Placement

This $10M Deal Could Reshape the Future of Global Creator Platforms

New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?

Featured Company

GMV Minerals Inc V.GMV

GMV Minerals Inc. is an exploration company focused on developing precious metal assets in Arizona. The Company, through its ... view more »